AzTrials
AzTrials

HypertensionZUMBA-BPNCT07735468

Effects of a 10-Week Zumba Program in Adults With Hypertension

A study testing Zumba fitness programme in people with Hypertension, run by Universidad de Extremadura at 1 site in Spain.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aims to evaluate the effects of a 10-week Zumba-based exercise program performed three times per week on blood pressure in adults with hypertension. In addition to the primary outcome of blood pressure, secondary outcomes including medication control, body composition (body weight, body fat percentage, and… Read more about this study

Who is it for?
Any age
Conditions the study is for
Hypertension
What is being tested?
Zumba fitness programme
Could I receive a placebo?
No, everyone receives an active treatment
How many people
46 participants
Where
1 siteSpain
Study dates
27 Apr 2026to 10 Jul 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Clinical diagnosis of hypertension defined as SBP ≥ 130 mmHg and/or DBP ≥ 80 mmHg
  • Sedentary behaviour during the past 12 months (no regular structured physical activity)
  • Age 18 years or older
  • Medical clearance to participate in supervised physical activity
  • Not having regularly practised Zumba or other dance disciplines during the previous 12 months

Who cannot join

  • resence of orthopaedic, neurological, or cardiovascular conditions contraindicating exercise
  • Unstable or uncontrolled hypertension
  • Participation in any other structured exercise programme during the intervention period
  • Missing more than 10% of the total sessions (more than 3 sessions)
  • Presence of any condition that would prevent safe completion of the programme

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • University School of Osuna (University of Seville)

    Osuna, Sevilla, 41640

Other trials in Spain

About this study

Official title: Effects of a 10-Week Zumba-Based Exercise Program on Blood Pressure, Medication Control, Body Composition, and Psychological Outcomes in Adults With Hypertension

This study aims to evaluate the effects of a 10-week Zumba-based exercise program performed three times per week on blood pressure in adults with hypertension. In addition to the primary outcome of blood pressure, secondary outcomes including medication control, body composition (body weight, body fat percentage, and muscle mass), and psychological outcomes (anxiety, depression, quality of life, emotional well-being, and sleep quality) will be assessed.

Participants will be assigned to either an intervention group, performing the Zumba program, or a control group maintaining their usual lifestyle. Measurements will be conducted at baseline and after the intervention period to determine the effectiveness of the program.

Read the detailed description

Hypertension is a major public health concern associated with increased cardiovascular risk. Regular physical activity has been shown to improve blood pressure control and overall health outcomes. Zumba, as a form of aerobic exercise combining dance and music, may represent an engaging and effective intervention to improve adherence to physical activity programs.

The aim of this study is to investigate the effects of a 10-week Zumba-based exercise intervention, performed three times per week, on blood pressure in adults with hypertension. Secondary objectives include the assessment of changes in medication use, body composition (body weight, body fat percentage, and muscle mass), and psychological outcomes, including anxiety and depression symptoms, quality of life, emotional well-being, and sleep quality.

Participants will be allocated to either an intervention group or a control group. The intervention group will participate in supervised Zumba sessions, while the control group will maintain their usual daily activities. All participants will undergo assessments at baseline and after the 10-week intervention period.

Conditions
Hypertension
Being tested
Zumba fitness programme
Keywords
Zumba, Hypertension, Blood Pressure, Physical Activity, Body Composition, Psychological Outcomes
Medical subject headings
Hypertension, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Zumba fitness programmeBehavioural

    Aquí tienes la descripción para el campo de intervención en ClinicalTrials.gov:

    A 10-week supervised Zumba Fitness programme consisting of three 50-minute sessions per week on non-consecutive days. Each session was structured in three phases: a warm-up (7 minutes), a main part (36 minutes) based on choreographed Latin dance rhythms (merengue, salsa, reggaeton, cumbia, bachata, among others) following a wave-like intensity pattern, and a cool-down (7 minutes). Sessions were led by a certified Zumba Instructor Network (ZIN) instructor with more than 10 years of experience. Internal load was self-regulated by participants using the Borg CR-10 scale, targeting moderate-to-hard effort levels (RPE 4-6). The control group maintained their usual sedentary lifestyle without participating in any structured exercise programme during the intervention period.

Study groups in NCT07735468
Study groupRoleWhat they receive
Zumba GroupExperimentalParticipants in this group will perform a supervised Zumba-based exercise program for 10 weeks, with a frequency of three sessions per week. Each session will consist of moderate-intensity aerobic exercise based on dance movements.
Receives: Behavioral: Zumba fitness programme
Group ControlNo interventionParticipants in this group will maintain their usual lifestyle and will not participate in the structured exercise program during the study period.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Systolic and Diastolic Blood Pressure

    Blood pressure will be measured at baseline and after the 10-week intervention using a validated sphygmomanometer.

    Measured: Baseline and 10 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Jul 2026
  2. Study start27 Apr 2026
  3. Primary completion6 Jul 2026
  4. Study completion10 Jul 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants will be randomly assigned to either a Zumba-based exercise intervention group or a control group maintaining their usual lifestyle, in a parallel design.
Masking
None (open label)
Enrolment
46 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07735468
Sponsor's protocol ID
ZU-BP-10WEEKS
Acronym
ZUMBA-BP
Status last verified
Apr 2026
First submitted
24 Jul 2026
Last updated
30 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Zumba fitness programme in people with Hypertension, run by Universidad de Extremadura at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Systolic and Diastolic Blood Pressure (time frame: Baseline and 10 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in